Assessment of socio-clinical and laboratory profile and short-term outcome among acute bronchiolitis children between 1–24 months in a tertiary care hospital: A prospective descriptive study.

Authors

  • Mohammad Amir Ali Senior Resident, Department of Paediatric, ESIC medical College & Hospital, Bihta Patna, Bihar, India Author
  • Chandra Sekhar Patra Assistant Professor, Department of Pediatrics, IMS & SUM Hospital, Bhubaneswar, Odisha, India Author
  • Sagar Parida Associate Professor, Department of Paediatrics, IMS & SUM Hospital, Bhubaneshwar, Odisha, India Author
  • Dillip Dash Professor, Department of Pediatrics, IMS & SUM Hospital, Bhubaneshwar, Odisha, India Author
  • Shivangi Maheshwari Postgraduate Trainee, Department of Pediatrics, IMS & SUM Hospital, Odisha, India Author
  • Ankita Chopdar Postgraduate Trainee, Department of Pediatrics, IMS & SUM Hospital, Odisha, India Author
  • Dr. Mamata Devi Mohanty HOD, Department of Paediatrics, IMS & SUM Hospital, Odisha, India. Author

DOI:

https://doi.org/10.51168/9g811v54

Keywords:

antibiotics, bronchiolitis, laboratory profile, respiratory syncytial virus (RSV), shortness of breath

Abstract

Background:

Bronchiolitis is a clinical syndrome that primarily affects infants and young children.

 Objectives:

To study the socio-clinical, laboratory profile, and short-term outcome among children with acute bronchiolitis between 1-24 months in a tertiary care hospital, and to analyze the identifiable risk factors for the severity of bronchiolitis.

 Material & Methods:

A Prospective descriptive study was carried out in IMS & SUM Hospital, Siksha O Anusandhan University, Bhubaneshwar, India, from May 2023 to May 2024. All previously normal or healthy children aged 1-24 months with a first episode of wheeze suggestive of bronchiolitis as per AAP guidelines were included in the study.

 Results:

A total of 171 cases were analyzed in our study, including 101 (59.1%) male and 70 (40.9%) female. Mean age was 6.78 months with a standard deviation of 4.66. Children less than 6 months accounted for 99 (57.9%) of cases. Bronchiolitis cases were increased in winter and early spring. Shortness of breath was present in 171 (100%) cases, followed by cough 108 (63.1%), fever 104 (60.8%), and poor feeding 92 (53.8%). Low birth weight, feeding pattern, indoor allergens, socioeconomic status, and passive smoking increase the severity of disease (P<0.05). Leukocytosis in 137 (80.1%) and raised CRP in 65 (38%) cases, with 04 (2.4%) cases having positive blood culture and sensitivity. 118 (68.8%) cases had positive chest X-rays. Nasopharyngeal swab was RSV positive in 84 (40.1%) cases. Among the treatments, 171 (100%) patients received hypertonic saline nebulization. Antibiotics were used in 69 (40.3%) and steroids in 47 (27.4%) cases. 26 (15.3%) cases were shifted to PICU.

 Conclusion:

Bronchiolitis predominantly affected infants below six months and showed a higher incidence during winter months.

 Recommendations:

Early identification of high-risk infants with bronchiolitis is essential to reduce disease severity and complications.

 

References

1. Sung RYT, Chan RCK, Tam JS, Cheng AFB, Murray HGS. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiology and Infection. 1992;108(1):147-154. 10.1017/s0950268800049591 https://doi.org/10.1017/S0950268800049591

2. Iqbal SMJ, Afzal MF, Sultan MA. Acute Bronchiolitis: Epidemiological and Clinical Study. Annals KEMU [Internet]. 2010 Apr. 20 [cited 2026 Feb. 12];15(4):203.

3. American Academy of Pediatrics| Clinical Practice Guideline| November 01, 2014 Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis: 10.1542/peds. 2014-2742

4. Kuppuswamy BJ. Manual of socioeconomic status (urban). Delhi: Manasayan. 1981;8(4):66-72.:

5. Flores-González JC, Matamala-Morillo MA, Rodríguez-Campoy P, Pérez-Guerrero JJ, Serrano-Moyano B, Comino-Vázquez P, et al. (2015)Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial. PLoS ONE 10(11):e0142847. 10.1371/journal.pone.0142847 https://doi.org/10.1371/journal.pone.0142847

6. A Uyan, H Ozyurek, M Keskin, Y Afsar, E Yilmaz. Comparison Of Two Different Bronchodilators In The Treatment of Acute Bronchiolitis. The Internet Journal of Pediatrics and Neonatology. 2002 Volume 3 Number 1: https://doi.org/10.5580/505

7. Fjaerli, HO., Farstad, T. & Bratlid, D. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr 4, 25 (2004). 10.1186/1471-2431-4-25 https://doi.org/10.1186/1471-2431-4-25

8. Nguyen, Sang Ngoc, Nguyen, Thuy Ngoc Thi, Vu, Lam Tung, Nguyen, Thap Duc, Clinical Epidemiological Characteristics and Risk Factors for Severe Bronchiolitis Caused by Respiratory Syncytial Virus in Vietnamese Children, International Journal of Pediatrics, 2021, 9704666, 6 pages, 2021. 10.1155/2021/9704666 https://doi.org/10.1155/2021/9704666

9. Joseph J. Zorc, Caroline Breese Hall. Bronchiolitis: Recent Evidence on Diagnosis and Management. Pediatrics (2010) 125 (2): 342-349.: 10.1542/peds. 2009-2092 https://doi.org/10.1542/peds.2009-2092

10. Carroll KN, Gebretsadik T, Griffin MR, Wu P, Dupont WD, Mitchel EF, Enriquez R, Hartert TV. Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics. 2008 Jul;122(1):58-64. 10.1542/peds. 2007-2087 https://doi.org/10.1542/peds.2007-2087

11. Downham MA, Scott R, Sims DG, Webb JK, Gardner PS: Breastfeeding protects against respiratory syncytial virus infections. Br Med J. 1976, 31:274-6: 10.1136/bmj.2.6030.274 https://doi.org/10.1136/bmj.2.6030.274

12. Simoes EA: Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003, 5:118-26. 10.1067/s0022-3476(03)00511-0 https://doi.org/10.1067/S0022-3476(03)00511-0

13. Robledo-Aceves, Mireya MDa; Moreno-Peregrina, María de Jesús MDa; Velarde-Rivera, Fernando MDb; Ascencio-Esparza, Elba BSb; Preciado-Figueroa, Francisco M. MDc; Caniza, Miguela A. MD, MPHd; Escobedo-Meléndez, Griselda MD, PhDe,f,*. Risk factors for severe bronchiolitis caused by respiratory virus infections among Mexican children in an emergency department. Medicine 97(9):p e0057, March 2018. 10.1097/MD.0000000000010057 https://doi.org/10.1097/MD.0000000000010057

14. Sznajder M, Stheneur C, Albonico V, Dib S, Cau D, Chevallier B; General Pediatrics Group of the French Society of Pediatrics: Respiratory development of 5- to 6- year-old children experiencing a first bronchiolitis episode before age one. Eur Ann Allergy Clin Immunol. 2005, 37:392-6.

15. Di Carlo P, Romano A, Salsa L, et al.: Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy. Ital J Pediatr 35. 11: 10.1186/1824-7288- 35-11 https://doi.org/10.1186/1824-7288-35-11

16. Isa, Hasan M., Mohroofi, Abdulrahman D., Alkhan, Fatema N., et al.; C-Reactive Protein Levels in Children with Acute Bronchiolitis, International Journal of Pediatrics, 2022, 1311936, 7 pages, 2022. 10.1155/2022/1311936 https://doi.org/10.1155/2022/1311936

17. Hussain F, Delgado Thompson M, Vick D, West J, Edwards M: Clinical severity of RSV bronchiolitis. Health Sci Rep.2022. 5:543. 10.1002/hsr2.543 https://doi.org/10.1002/hsr2.543

18. Yusuf Alakaş, Can Celiloğlu, Orkun Tolunay, Selçuk Matyar, The Relationship between Bronchiolitis Severity and Vitamin D Status. Journal of Tropical Pediatrics, Volume 67, Issue 4, August 2021081, 10.1093/tropej/fmab081 https://doi.org/10.1093/tropej/fmab081

19. Zhang L, Mendoza‐Sassi RA, Wainwright C, Klassen TP: Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews. 2017, 12:006458. 10.1002/14651858.CD006458.pub4

20. Wainwright C: Acute viral bronchiolitis in children- a very common condition with few therapeutic options. Paediatr Respir Rev. 201011, 39-45. 10.1016/j.prrv.2009.10.001 https://doi.org/10.1016/j.prrv.2009.10.001

21. Kellner JD, Ohlsson A, Gadomski AM, Wang EE: Efficacy of bronchodilator therapy in bronchiolmeta-analysisanalysis. Arch Pediatr Adolesc Med. 1996, 150:1166-72. 10.1001/archpedi. 1996.02170360056009 https://doi.org/10.1001/archpedi.1996.02170360056009

22. Fernandes RM: Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013, 4:004878. 10.1002/14651858.cd004878.pub4 https://doi.org/10.1002/14651858.CD004878.pub4

23. Antonow JA, Hansen K, McKinstry CA, Byington CL: Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J. 1998, 17:231-6. 10.1097/00006454-199803000-00011 https://doi.org/10.1097/00006454-199803000-00011

24. Purcell K, Fergie J: Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2007, 26:311-5. 10.1097/01.inf.0000258627.23337.00 https://doi.org/10.1097/01.inf.0000258627.23337.00

Downloads

Published

2026-05-14

Issue

Section

Section of other peer-reviewed articles

How to Cite

Assessment of socio-clinical and laboratory profile and short-term outcome among acute bronchiolitis children between 1–24 months in a tertiary care hospital: A prospective descriptive study. (M. A. Ali, C. S. Patra, S. Parida, D. Dash, S. Maheshwari, A. Chopdar, & D. M. D. Mohanty, Trans.). (2026). SJ Pediatrics and Child Health Africa, 3(2), 13. https://doi.org/10.51168/9g811v54

Similar Articles

You may also start an advanced similarity search for this article.